Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/96907
Full metadata record
DC FieldValueLanguage
dc.contributor.CRUESPUNIVERSIDADE DE ESTADUAL DE CAMPINASpt_BR
dc.typeArtigo de periódicopt_BR
dc.titleExopolysaccharide Matrix Of Developed Candida Albicans Biofilms After Exposure To Antifungal Agentspt_BR
dc.contributor.authorDa Silva W.J.pt_BR
dc.contributor.authorGoncalves L.M.pt_BR
dc.contributor.authorSeneviratne J.pt_BR
dc.contributor.authorParahitiyawa N.pt_BR
dc.contributor.authorSamaranayake L.P.pt_BR
dc.contributor.authorDel Bel Cury A.A.pt_BR
unicamp.authorDa Silva, W.J., Department of Prosthodontics and Periodontology, Piracicaba Dental School, UNICAMP - University of Campinas, Piracicaba, SP, Brazilpt_BR
unicamp.authorGonçalves, L.M., Department of Prosthodontics and Periodontology, Piracicaba Dental School, UNICAMP - University of Campinas, Piracicaba, SP, Brazilpt_BR
unicamp.authorDel Bel Cury, A.A., Department of Prosthodontics and Periodontology, Piracicaba Dental School, UNICAMP - University of Campinas, Piracicaba, SP, Brazilpt_BR
unicamp.author.externalSeneviratne, J., Oral Biosciences, Faculty of Dentistry, The University of Hong Kong, Pokfulam, Hong Kongpt
unicamp.author.externalParahitiyawa, N., Faculty of Medicine, University of Peradeniya, Colombo, Sri Lankapt
unicamp.author.externalSamaranayake, L.P., Oral Biosciences, Faculty of Dentistry, The University of Hong Kong, Pokfulam, Hong Kongpt
dc.description.abstractThis study aimed to evaluate the effects of fluconazole or nystatin exposure on developed Candida albicans biofilms regarding their exopolysaccharide matrix. The minimal inhibitory concentration (MIC) against fluconazole or nystatin was determined for C. albicans reference strain (ATCC 90028). Poly(methlymethacrylate) resin (PMMA) specimens were fabricated according to the manufacturer's instructions and had their surface roughness measured. Biofilms were developed on specimens surfaces for 48 h and after that were exposed during 24 h to fluconazole or nystatin prepared in a medium at MIC, 10 x MIC or 100 x MIC. Metabolic activity was evaluated using an XTT assay. Production of soluble and insoluble exopolysaccharide and intracellular polysaccharides was evaluated by the phenol-sulfuric method. Confocal laser scanning microscope was used to evaluate biofilm architecture and percentage of dead/live cells. Data were analyzed statistically by ANOVA and Tukey's test at 5% significance level. The presence of fluconazole or nystatin at concentrations higher than MIC results in a great reduction of metabolic activity (p<0.001). At MIC or 10 x MIC, fluconazole showed high amounts of intracellular polysaccharides (p<0.05), but did not affect the exopolysaccharide matrix (p>0.05). The exposure to nystatin also did not alter the exopolysaccharide matrix at all the tested concentrations (p>0.05). Biofilm architecture was not affected by either of the antifungal agents (p>0.05). Nystatin promoted higher proportion of dead cells (p<0.05). It may be concluded that fluconazole and nystatin above the MIC concentration reduced the metabolic activity of C. albicans biofilms; however, they were not able to alter the exopolysaccharide matrix and biofilm architecture.en
dc.relation.ispartofBrazilian Dental Journalpt_BR
dc.date.issued2012pt_BR
dc.identifier.citationBrazilian Dental Journal. , v. 23, n. 6, p. 716 - 722, 2012.pt_BR
dc.language.isoenpt_BR
dc.description.volume23pt_BR
dc.description.issuenumber6pt_BR
dc.description.firstpage716pt_BR
dc.description.lastpage722pt_BR
dc.rightsabertopt_BR
dc.sourceScopuspt_BR
dc.identifier.issn1036440pt_BR
dc.identifier.doi10.1590/S0103-64402012000600016pt_BR
dc.identifier.urlhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84872978033&partnerID=40&md5=1bbc35010ec2846c1b841d9fc8ef3cecpt_BR
dc.date.available2015-06-26T20:29:09Z
dc.date.available2015-11-26T14:25:32Z-
dc.date.accessioned2015-06-26T20:29:09Z
dc.date.accessioned2015-11-26T14:25:32Z-
dc.description.provenanceMade available in DSpace on 2015-06-26T20:29:09Z (GMT). No. of bitstreams: 0 Previous issue date: 2012en
dc.description.provenanceMade available in DSpace on 2015-11-26T14:25:32Z (GMT). No. of bitstreams: 0 Previous issue date: 2012en
dc.identifier.urihttp://www.repositorio.unicamp.br/handle/REPOSIP/96907
dc.identifier.urihttp://repositorio.unicamp.br/jspui/handle/REPOSIP/96907-
dc.identifier.idScopus2-s2.0-84872978033pt_BR
dc.description.referenceGendreau, L., Loewy, Z.G., Epidemiology and etiology of denture stomatitis (2011) J Prosthodont, 20, pp. 251-260pt_BR
dc.description.referenceTobudic, S., Kratzer, C., Lassnigg, A., Presterl, E., Antifungal susceptibility of Candida albicans in biofilms (2012) Mycoses, 55, pp. 199-204pt_BR
dc.description.referenceChaffin, W.L., Candida albicans cell wall proteins (2008) Microbiol Mol Biol Rev, 72, pp. 495-544pt_BR
dc.description.referenceSeneviratne, C.J., Jin, L., Samaranayake, L.P., Biofilm lifestyle of Candida: A mini review (2008) Oral Dis, 14, pp. 582-590pt_BR
dc.description.referenceRamage, G., Rajendran, R., Sherry, L., Williams, C., Fungal biofilm resistance (2012) Int J Microbiol, , 528-521pt_BR
dc.description.referenceChandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., Ghannoum, M.A., Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance (2001) J Bacteriol, 183, pp. 5385-5394pt_BR
dc.description.referenceKonopka, K., Dorocka-Bobkowska, B., Gebremedhin, S., Duzgunes, N., Susceptibility of Candida biofilms to histatin 5 and fluconazole (2010) Antonie Van Leeuwenhoek, 97, pp. 413-417pt_BR
dc.description.referenceBaillie, G.S., Douglas, L.J., Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents (1998) Antimicrob Agents Chemother, 42, pp. 1900-1905pt_BR
dc.description.referenceNiimi, M., Firth, N.A., Cannon, R.D., Antifungal drug resistance of oral fungi (2010) Odontology, 98, pp. 15-25pt_BR
dc.description.referenceRamage, G., Mowat, E., Jones, B., Williams, C., Lopez-Ribot, J., Our current understanding of fungal biofilms (2009) Crit Rev Microbiol, 35, pp. 340-355pt_BR
dc.description.referenceBaillie, G.S., Douglas, L.J., Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents (2000) J Antimicrob Chemother, 46, pp. 397-403pt_BR
dc.description.referenceSeneviratne, C.J., Jin, L.J., Samaranayake, Y.H., Samaranayake, L.P., Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms (2008) Antimicrob Agents Chemother, 52, pp. 3259-3266pt_BR
dc.description.referenceda Silva, W.J., Seneviratne, J., Samaranayake, L.P., Del Bel Cury, A.A., Bioactivity and architecture of Candida albicans biofilms developed on poly (methyl methacrylate) resin surface (2010) J Biomed Mater Res B Appl Biomater, 94, pp. 149-156pt_BR
dc.description.reference(2008) Reference Method For Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard, , CLSI, CLSI Document M27-A3, Wayne, PA:CLSIpt_BR
dc.description.referenceda Silva, W.J., Seneviratne, J., Parahitiyawa, N., Rosa, E.A., Samaranayake, L.P., Del Bel Cury, A.A., Improvement of XTT assay performance for studies involving Candida albicans biofilms (2008) Braz Dent J, 19, pp. 364-369pt_BR
dc.description.referenceTenuta, L.M., Ricomini, F.A.P., Del Bel Cury, A.A., Cury, J.A., Effect of sucrose on the selection of mutans streptococci and lactobacilli in dental biofilm formed in situ (2006) Caries Res, 40, pp. 546-549pt_BR
dc.description.referenceDubois, M., Gilles, K., Hamilton, J.K., Rebers, P.A., Smith, F., A colorimetric method for the determination of sugars (1951) Nature, 28, p. 167. , 168pt_BR
dc.description.referenceHeydorn, A., Nielsen, A.T., Hentzer, M., Sternberg, C., Givskov, M., Ersboll, B.K., Quantification of biofilm structures by the novel computer program COMSTAT (2000) Microbiology, 146, pp. 2395-2407pt_BR
dc.description.referenceForce, R.W., Nahata, M.C., Salivary concentrations of ketoconazole and fluconazole: Implications for drug efficacy in oropharyngeal and esophageal candidiasis (1995) Ann Pharmacother, 29, pp. 10-15pt_BR
dc.description.referenceGomes, P.N., da Silva, W.J., Pousa, C.C., Narvaes, E.A., Del Bel Cury, A.A., Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole (2011) Arch Oral Biol, 56, pp. 1274-1281pt_BR
dc.description.referenceEllepola, A.N., Samaranayake, L.P., Oral candidal infections and antimycotics (2000) Crit Rev Oral Biol Med, 11, pp. 172-198pt_BR
dc.description.referenceEllepola, A.N., Samaranayake, L.P., The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion (1998) Oral Dis, 4, pp. 260-267pt_BR
dc.description.referenceNett, J.E., Sanchez, H., Cain, M.T., Andes, D.R., Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan (2010) J Infect Dis, 202, pp. 171-175pt_BR
dc.description.referenceMores, A.U., Souza, R.D., Cavalca, L., de Paula e Carvalho, A., Gursky, L.C., Rosa, R.T., Enhancement of secretory aspartyl protease production in biofilms of Candida albicans exposed to subinhibitory concentrations of fluconazole (2011) Mycoses, 54, pp. 195-201pt_BR
dc.description.referenceGoncalves, L.M., Del Bel Cury, A.A., Sartoratto, A., Garcia, R.V.L., Silva, W.J., Effects of undecylenic acid released from denture liner on Candida biofilms (2012) J Dent Res, 91, pp. 985-989pt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.